Caption Guidance vs Lung AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Caption Guidance

by Caption Health

Lung AI

by Exo

AI Verdict

Tool A, Caption Guidance, specializes in AI-guided acquisition and quality assessment for cardiac ultrasound, integrating as a software accessory into compatible diagnostic systems. In contrast, Tool B, Exo's Lung AI, is integrated into a handheld ultrasound device, offering AI-powered detection for both cardiac conditions and specific lung pathologies like pleural effusion and consolidation. While both leverage AI for cardiac imaging, their deployment models and specific feature sets cater to somewhat different clinical workflows and diagnostic scopes, with Tool B offering broader POCUS capabilities.

Choose Caption Guidance if…

Choose Caption Guidance if your primary need is to consistently acquire high-quality, diagnostic cardiac ultrasound images, especially when performed by clinicians who may benefit from real-time AI guidance on probe manipulation and automated quality assessment. This tool is ideal for integrating into existing compatible cart-based ultrasound systems to standardize cardiac imaging protocols and improve diagnostic accuracy.

View Caption Guidance →

Choose Lung AI if…

Choose Lung AI if you require a highly portable, handheld ultrasound solution for rapid, point-of-care assessment of lung pathologies like pleural effusion or consolidation, alongside key cardiac indicators. Its on-device AI processing makes it suitable for emergency medicine, critical care, or remote settings where immediate decisions are crucial and internet connectivity may be unreliable.

View Lung AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Caption Guidance	Lung AI
Pricing	Unknown	Contact for pricing
Deployment	On-premise (integrated with ultrasound equipment) and cloud-based services.	On-device (integrated with Exo Iris handheld ultrasound device)
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Caption Guidance

Caption Guidance offers explicit 'real-time, turn-by-turn prompts' for ultrasound probe manipulation and a 'Quality Meter' to guide users to diagnostic-quality images. Its effectiveness has been clinically validated for users with no prior scanning experience to acquire diagnostic-quality echocardiograms, emphasizing its ease of use for novice operators.

Clinical Value

Lung AI

Lung AI provides direct AI-powered detection of specific conditions like pleural effusion and consolidation/atelectasis, alongside automated indicators for cardiac conditions and ejection fraction calculation. Clinical studies demonstrate that AI assistance significantly improves diagnostic sensitivity, particularly for less experienced users, offering immediate interpretive value at the point of care.

Pricing & Value

Lung AI

Exo's Iris system, which integrates Lung AI, offers transparent, publicly available pricing, with a starting price of $3,500 and clear subscription plans for its software. In contrast, Caption Guidance requires contacting the vendor for enterprise pricing, offering less immediate transparency for potential buyers.

Enterprise Readiness

Caption Guidance

Caption Guidance, now part of GE HealthCare, is designed as a software accessory integrated into compatible GE HealthCare ultrasound systems, such as the Venue Family and Vscan Air SL. This integration with an established major vendor's ecosystem, coupled with its FDA clearance, HIPAA compliance, and BAA, provides a robust pathway for large-scale enterprise deployment and support.

Innovation

Lung AI

Exo's Lung AI is part of a pioneering high-performance, handheld ultrasound platform with on-device AI processing that operates without internet, offering broad diagnostic detection capabilities across multiple specialties. It is also the first FDA-cleared AI for detecting pleural effusion and consolidation/atelectasis on a handheld device. This combination of platform, on-device AI, and diverse diagnostic applications represents a comprehensive innovation for point-of-care accessibility.

Support & Docs

Lung AI

Exo explicitly lists 'Exo U (AI-powered POCUS education and training)' as a key feature, demonstrating a direct commitment to user education and support [cite: JSON]. Additionally, its subscription plans include active support and cloud storage, providing clear and documented resources for users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Caption Guidance	Lung AI
Name	Caption Guidance	Lung AI
Company	Caption Health (now part of GE HealthCare)	Exo
Tagline	Empowering Clinicians with AI-Guided Cardiac Ultrasound	Handheld AI Ultrasound for Smarter Cardiac and Lung Scanning.
Key Features	Real-time AI guidance for ultrasound probe manipulation, Automated quality assessment with a 'Quality Meter', Auto-capture of diagnostic-quality ultrasound clips, Automated ejection fraction calculation (as part of Caption AI/Interpretation), Adjustable scanning protocols for up to 10 key cardiac views, Preliminary probe placement information, Real-time feedback on diagnostic image quality, Compatible with GE HealthCare Venue Family and Vscan Air SL ultrasound systems.	AI-powered detection of pleural effusion, AI-powered detection of consolidation/atelectasis, Real-time feedback and image quality monitoring (SweepAI), Automated AI-based indicators for cardiac conditions (e.g., heart failure, hypertrophy), Guided image capture for optimal scans, On-device AI processing (operates without internet), Pulsed-wave Doppler capabilities (on Exo Iris), Exo U (AI-powered POCUS education and training).
Specialties	Cardiology, Critical Care, Radiology	Cardiology, Emergency Medicine, Pulmonology

Videos

Demos, reviews, and walkthroughs featuring Caption Guidance and Lung AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do the specific clinical applications and AI capabilities differ between Caption Guidance and Lung AI, particularly regarding cardiac versus lung assessments?

Caption Guidance is designed to empower healthcare providers to acquire diagnostic-quality cardiac ultrasound images with real-time AI guidance, automated quality assessment, and auto-capture of clips, including automated ejection fraction calculation. In contrast, Lung AI focuses on AI-powered detection of pleural effusion and consolidation/atelectasis, along with automated AI-based indicators for cardiac conditions such as heart failure and hypertrophy, all within a handheld ultrasound platform.

How does each tool integrate into an existing clinical workflow, considering the type of ultrasound system required?

Caption Guidance is a software accessory integrated into compatible general-purpose diagnostic ultrasound systems, specifically GE HealthCare Venue Family and Vscan Air SL systems, fitting into existing GE ultrasound workflows. Lung AI is integrated on-device with the Exo Iris handheld ultrasound device, suggesting a workflow centered around a portable, dedicated point-of-care ultrasound (POCUS) system.

What features or resources are available to support the learning curve for physicians new to using these AI-guided ultrasound tools?

Caption Guidance provides real-time AI guidance for ultrasound probe manipulation, preliminary probe placement information, and real-time feedback on diagnostic image quality to assist users in acquiring optimal images. Lung AI supports users with guided image capture for optimal scans and offers 'Exo U,' an AI-powered POCUS education and training platform.

What level of support for diagnostic confidence can be expected from the AI-driven assessments or image quality guidance provided by each tool?

Caption Guidance aims to enhance diagnostic confidence by guiding users to acquire diagnostic-quality cardiac ultrasound images with real-time feedback, automated quality assessment via a 'Quality Meter', and auto-capture of optimal clips. Lung AI provides AI-powered detection of specific conditions like pleural effusion and consolidation/atelectasis, automated AI-based indicators for cardiac conditions, and real-time feedback with image quality monitoring (SweepAI), with studies showing high sensitivity and specificity for its detections.

Beyond standard compliance, what specific architectural choices or features does each tool offer to enhance the security of patient data during image acquisition and processing?

Caption Guidance operates as a software accessory integrated into compatible diagnostic ultrasound systems, and its security posture would largely depend on the host system's security features and adherence to HIPAA guidelines. Lung AI's on-device AI processing, which operates without an internet connection, inherently reduces the need for patient data transmission over networks, potentially enhancing data security by keeping processing local.